Company news
Endonovo Therapeutics, Inc. news in 2020
Endonovo Therapeutics, Inc.'s news releases, calls and decks from 2020, newest first.
Endonovo Therapeutics’ Offers FDA Cleared Solution to Opioid Epidemic Which Has Significantly Increased During the COVID Pandemic.
October 8, 2020
Endonovo Therapeutics Announces Encore Live Webinar of Baylor College of Medicine Study For Patients Undergoing Cardiothoracic Surgery Showing Reduction of Pain and Opioid Use With Significant Reduction of Length of Stay Using SofPulse®
September 9, 2020
Endonovo Therapeutics, Inc. Announces Second Quarter Fiscal 2020 Financial Results
August 20, 2020
Endonovo Therapeutics Announces Significant Results From Study Showing 70% Reduction of Morphine Equivalent Dose and 2 Day Reduction of Length of Stay at Hospitals Using SofPulse®
July 27, 2020
Endonovo Therapeutics Announces Effectiveness of Registration of Equity Credit Line and Ceasing Variable Convertible Note Financing
July 21, 2020
Endonovo Therapeutics Announces First Quarter Fiscal 2020 Financial Results
June 15, 2020
Endonovo Therapeutics Announces International Expansion with Distribution Agreement for SofPulse® in Taiwan, Republic of China
June 1, 2020
Endonovo Therapeutics Enters into $10 million Equity Line Agreement with Cavalry Fund
May 26, 2020
Endonovo Therapeutics Announces Positive 2019 Fiscal Results
May 4, 2020
Endonovo Therapeutics Announces Eight Additional Hospitals Approved Use of SofPulse® at Their Facilities
April 16, 2020
Endonovo Therapeutics seeks Intensive Care Unit Partners for Investigational Adjunctive Treatment for Severe Respiratory Inflammatory Complications for COVID-19 Patients.
March 25, 2020
Endonovo to Donate SofPulse® Units for Investigational Use to Evaluate Inhibition of Inflammatory Symptoms Associated with COVID-19
March 16, 2020
Endonovo Therapeutics Files 8K With SEC Regarding SofPulse®
March 2, 2020
Endonovo Therapeutics Introduces Support of SofPulse® With A New Ancillary Multi-Use Patient Brace From Protex
February 24, 2020
Endonovo Therapeutics Begins Process For Medical Reimbursements
February 20, 2020
Endonovo Therapeutics Announces collaborating with a Stanford University sponsored Orthopedic Shoulder and Knee Study
February 13, 2020
Endonovo Therapeutics announces its collaboration with Major Universities for the Evaluation of SofPulse® for Orthopedic Surgeries
February 10, 2020
Endonovo Therapeutics Reduces Debt
February 4, 2020
Endonovo Therapeutics Expands SofPulse® Sales to Plastic Surgery Centers
January 30, 2020
Endonovo Therapeutics Announces First SofPulse® Sales to a Veterans Medical Center
January 27, 2020
Endonovo Therapeutics Announces Issuance of Broad Patent Covering Electromagnetic Treatment of Multiple Sclerosis
January 14, 2020
Endonovo Therapeutics Announces Issuance of U.S. Patent Covering Apparatus and Method for Electromagnetic Treatment of Neurological Injury or Condition Caused by a Stroke
January 7, 2020
Decks in 2020
- Investor Presentation (March 2020)
Investor deck · 26 slides · Mar 2, 2020